Intrinsic Value
Fate Therapeutics, Inc. (FATE)
$7.34
+0.01 (+0.00%)
Enterprise Value | -42,924.85 |
---|---|
Net Debt | 61.67 |
Equity Value | -42,986.52 |
Shares Outstanding | 98.41 |
Equity Value Per Share | -436.81 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt